Previous 10 | Next 10 |
2023-05-14 03:56:00 ET Summary Industry-leading pharmaceutical firms are adopting artificial intelligence to drive value for the future of their enterprise. Several companies in the VanEck Pharmaceutical ETF are currently integrating AI into their operations. The global pharma...
2023-05-12 09:15:18 ET Allakos ( NASDAQ: ALLK ) rose ~8% pre-market Friday after Jefferies upgraded the immunology-focused biotech to Buy from Hold, citing an attractive risk-reward setup ahead of a Phase 2 readout for its lead candidate lirentelimab. San Carlos, California-...
2023-05-12 07:30:07 ET Celcuity ( NASDAQ: CELC ) reported updated data from a phase 1b trial of gedatolisib in combination with Pfizer's ( PFE ) Ibrance (palbociclib) and Novartis' ( NVS ) Femara (letrozole) to treat patients with breast cancer at the 2023 Eur...
2023-05-10 07:05:51 ET Summary Since publishing the last article on PTC Therapeutics, the company's share price has risen 31.28%, outperforming the iShares Biotechnology ETF and the S&P 500. Overall, risdiplam is the company's third-highest-grossing medicine, with sales of CHF...
2023-05-08 05:28:36 ET Summary Shares of oral monoclonal antibody developer DICE Therapeutics, Inc. (DICE) go into the spotlight for the first time today. The company recently posted encouraging Phase 1c data from its lead candidate, psoriasis therapy DC-806, which demonstrated bo...
2023-05-04 05:41:30 ET Novartis' ( NYSE: NVS ) unit Sandoz signed a distribution agreement with Adalvo to get exclusive rights to commercialize six products in the U.S. in areas of antifungal/antibiotic, cancer and pulmonary. These products from Adalvo are slated for near...
2023-05-03 07:15:00 ET Summary The 2023 recession is likely to be mild, but the debt ceiling crisis means that a 15% to 30% market correction is likely coming soon. Trust ultra low volatility aristocrats rather than market timing to help you sleep well at night in the coming marke...
2023-05-03 06:08:01 ET The rate of drug overdose deaths involving fentanyl rose 279% between 2016 and 2021, according to a report from the U.S. Centers for Disease Control and Prevention (CDC). Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times...
2023-05-02 08:45:56 ET Palm Beach, FL – May 2, 2023 – FinancialNewsMedia.com News Commentary – The Global Dry Eye Syndrome market is witnessing continued growth due to the factors such as the growing demand for effective treatments, the rising prevalence of ...
2023-05-01 16:51:05 ET Summary The May 2022 total return portfolio for 1-year is up +17.09%, and the May 2021 2-year portfolio is up 21.33%, not adjusted for greater than 2%+ dividends. The first May 2020 portfolio had +66.98% 2-year returns. 40 portfolios have been formed sin...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...